Stay updated on Nivolumab for ALK+ ALCL: Clinical Trial
Sign up to get notified when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.

Latest updates to the Nivolumab for ALK+ ALCL: Clinical Trial page
- Check6 days agoNo Change Detected
- Check13 days agoNo Change Detected
- Check20 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; this appears to be a backend/formatting update with no impact on study data. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.1%

- Check28 days agoChange DetectedThe government funding/operating status notice and links (cc.nih.gov, opm.gov) at the top of the page have been removed.SummaryDifference0.4%

- Check42 days agoChange DetectedThe new screenshot appears to replicate the study record with formatting adjustments only; core content such as the study title, design, eligibility criteria, interventions, endpoints, and locations is unchanged. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check71 days agoChange DetectedUpdated core content with a government funding notice and NIH Clinical Center operating status, and bumped software version from v3.1.0 to v3.2.0.SummaryDifference3%

- Check78 days agoChange DetectedVersion updated from v3.0.2 to v3.1.0. This is an incremental update to the page metadata; no user-facing content changes detected.SummaryDifference0.1%

- Check92 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2; the 'Back to Top' element was removed.SummaryDifference0.2%

Stay in the know with updates to Nivolumab for ALK+ ALCL: Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab for ALK+ ALCL: Clinical Trial page.